RecruitingPhase 1 / Phase 2NCT06162221
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Sponsor: Revolution Medicines, Inc.
Fairfax, VA · +28 more sites
Lung Cancer clinical trials in Fairfax, VA
58 recruiting lung cancer studies with a site in Fairfax, VA.
RecruitingPhase 1NCT06179069
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Fairfax, VA · +10 more sites
RecruitingPhase 3NCT06623422
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Sponsor: Merck Sharp & Dohme LLC
Fairfax, VA · Norfolk, VA · Richmond, VA · +51 more sites
RecruitingPhase 1 / Phase 2NCT06810544
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Sponsor: Tango Therapeutics, Inc.
Fairfax, VA · +14 more sites
RecruitingPhase 1 / Phase 2NCT07038343
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Sponsor: Avenzo Therapeutics, Inc.
Fairfax, VA · +18 more sites
RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Fairfax, VA · +44 more sites
RecruitingPhase 1NCT06545331
Study of XB010 in Subjects With Solid Tumors
Sponsor: Exelixis
Fairfax, VA · +14 more sites
RecruitingPhase 2 / Phase 3NCT06712316
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
Sponsor: BioNTech SE
Arlington, VA · Fairfax, VA · Richmond, VA · +50 more sites
RecruitingPhase 1 / Phase 2NCT07020221
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Sponsor: Verastem, Inc.
Charlottesville, VA · Fairfax, VA · +11 more sites
RecruitingPhase 3NCT07625644
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Sponsor: SystImmune Inc.
Fairfax, VA · +6 more sites
RecruitingPhase 3NCT06712355
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Sponsor: BioNTech SE
Fairfax, VA · Fredericksburg, VA · Richmond, VA · +33 more sites
RecruitingPhase 1 / Phase 2NCT05786924
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Sponsor: Institut de Recherches Internationales Servier
Fairfax, VA · +20 more sites
RecruitingPhase 1NCT07094204
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Sponsor: Astellas Pharma Inc
Fairfax, VA · +10 more sites
RecruitingPhase 3NCT07128199
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Sponsor: Taiho Oncology, Inc.
Arlington, VA · Fairfax, VA · Manassas, VA · +27 more sites
RecruitingPhase 1NCT07519655
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Sponsor: Pfizer
Fairfax, VA · +9 more sites
RecruitingPhase 1 / Phase 2NCT05579366
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Sponsor: Genmab
Fairfax, VA · Norfolk, VA · +35 more sites
RecruitingPhase 3NCT06119581
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Sponsor: Eli Lilly and Company
Charlottesville, VA · Fairfax, VA · Richmond, VA · +84 more sites
RecruitingPhase 2NCT06780098
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Sponsor: Merck Sharp & Dohme LLC
Fairfax, VA · +3 more sites
RecruitingPhase 2NCT05967689
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
Sponsor: Taiho Oncology, Inc.
Fairfax, VA · +17 more sites
RecruitingPhase 1 / Phase 2NCT05797168
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Sponsor: AstraZeneca
Fairfax, VA · +12 more sites
RecruitingPhase 2 / Phase 3NCT07005102
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Sponsor: AbbVie
Fairfax, VA · +17 more sites
RecruitingPhase 1NCT07454642
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Sponsor: Avacta Life Sciences Ltd
Fairfax, VA · +6 more sites
RecruitingPhase 1NCT06270706
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Sponsor: Pliant Therapeutics, Inc.
Fairfax, VA · +14 more sites
RecruitingPhase 1 / Phase 2NCT06362252
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
Sponsor: Daiichi Sankyo
Fairfax, VA · +25 more sites
RecruitingPhase 1NCT07814248
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Sponsor: TwoStep Therapeutics, Inc.
Fairfax, VA · +2 more sites
RecruitingPhase 1NCT07277413
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Sponsor: IDEAYA Biosciences
Fairfax, VA · +22 more sites
RecruitingPhase 2 / Phase 3NCT07063745
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Sponsor: Bristol-Myers Squibb
Fairfax, VA · Richmond, VA · +42 more sites
RecruitingPhase 1 / Phase 2NCT07488676
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.
Fairfax, VA · +17 more sites
RecruitingPhase 1NCT05983432
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Sponsor: SystImmune Inc.
Fairfax, VA · +21 more sites
RecruitingPhase 1 / Phase 2NCT07629960
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Sponsor: Blueprint Medicines Corporation
Fairfax, VA · +9 more sites
RecruitingPhase 3NCT06767514
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Sponsor: Summit Therapeutics
Blacksburg, VA · Charlottesville, VA · Fairfax, VA · +94 more sites
RecruitingPhase 1 / Phase 2NCT07730021
A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
Sponsor: Astellas Pharma Global Development, Inc.
Fairfax, VA · +1 more sites
RecruitingPhase 1 / Phase 2NCT04486833
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Sponsor: Genprex, Inc.
Fairfax, VA · Norfolk, VA · +8 more sites
RecruitingPhase 1NCT07080242
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
Sponsor: SystImmune Inc.
Fairfax, VA · +23 more sites
RecruitingPhase 1NCT07217171
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Sponsor: EvolveImmune United, Inc
Fairfax, VA · +15 more sites
RecruitingPhase 1 / Phase 2NCT07491497
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
Sponsor: TRIANA Biomedicines, Inc.
Fairfax, VA · +13 more sites
RecruitingPhase 1NCT05245500
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Sponsor: Bristol-Myers Squibb
Fairfax, VA · +24 more sites
RecruitingPhase 1 / Phase 2NCT06043817
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
Sponsor: Pierre Fabre Medicament
Fairfax, VA · +8 more sites
RecruitingPhase 1 / Phase 2NCT06892548
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Sponsor: BioNTech SE
Fairfax, VA · +16 more sites
RecruitingPhase 1NCT07784959
Study of NXP900 With Lorlatinib in ALK+ Lung Cancer
Sponsor: Nuvectis Pharma, Inc.
Fairfax, VA
RecruitingPhase 1 / Phase 2NCT06706076
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Sponsor: BlossomHill Therapeutics
Fairfax, VA · +23 more sites
RecruitingPhase 1 / Phase 2NCT05098132
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Sponsor: Synthekine
Fairfax, VA · +32 more sites
RecruitingPhase 1NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Fairfax, VA · +105 more sites
RecruitingPhase 1NCT07300150
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Sponsor: PAQ Therapeutics, Inc.
Fairfax, VA · +4 more sites
RecruitingPhase 1 / Phase 2NCT07538804
A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer
Sponsor: Avistone Biotechnology Co., Ltd.
Fairfax, VA
RecruitingPhase 1NCT07046923
A Study of LY4175408 in Participants With Advanced Cancer
Sponsor: Eli Lilly and Company
Fairfax, VA · +14 more sites
RecruitingPhase 1NCT07540572
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Sponsor: IDEAYA Biosciences
Fairfax, VA · +10 more sites
RecruitingPhase 1 / Phase 2NCT05379985
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Sponsor: Revolution Medicines, Inc.
Fairfax, VA · +20 more sites
RecruitingPhase 2NCT05456256
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Sponsor: Lantern Pharma Inc.
Fairfax, VA · +5 more sites
RecruitingPhase 1NCT07424547
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Sponsor: Conjupro Biotherapeutics, Inc.
Fairfax, VA · +4 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.